Posted by Michael Wonder on 10 Mar 2020
HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?
10 March 2020 - For at least two decades, health technology assessment has been considered worldwide the most comprehensive and suitable approach to support health policy decision making for specific technologies.
Many associations have been founded all over the world and the number of publications including it in the title has reached around a thousand in the last decade.
The first move for coordination of health technology assessment in Europe was the EUR-ASSESS project, funded by the European Commission (EC) in the mid 1990s, followed by two other projects (again funded by the EC), which led to the establishment in 2006 of EUnetHTA; this large network of organizations—still currently funded by the EC until 2020—aims at supporting HTA as a decision-making tool for the EU and its Member States.
